The value of PET/CT radiomics for predicting survival outcomes in patients with pancreatic ductal adenocarcinoma

Abstract Pancreatic ductal adenocarcinoma (PDAC) is associated with poor prognosis even without distant metastases, necessitating in-depth characterization of primary tumors for survival prediction. We assessed the feasibility of using FDG-PET/CT radiomics to predict overall survival (OS) in PDAC. T...

Full description

Saved in:
Bibliographic Details
Main Authors: Yeon-koo Kang, Seunggyun Ha, Ji Bong Jeong, So Won Oh
Format: Article
Language:English
Published: Nature Portfolio 2024-11-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-77022-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850162882877063168
author Yeon-koo Kang
Seunggyun Ha
Ji Bong Jeong
So Won Oh
author_facet Yeon-koo Kang
Seunggyun Ha
Ji Bong Jeong
So Won Oh
author_sort Yeon-koo Kang
collection DOAJ
description Abstract Pancreatic ductal adenocarcinoma (PDAC) is associated with poor prognosis even without distant metastases, necessitating in-depth characterization of primary tumors for survival prediction. We assessed the feasibility of using FDG-PET/CT radiomics to predict overall survival (OS) in PDAC. This retrospective study included PDAC patients without distant metastasis who underwent FDG-PET/CT for initial staging. Primary tumors were segmented from FDG-PET/CT images, extracting 222 radiomics features. A radiomics-based risk score (Rad-score) was developed using Cox proportional hazards regression with LASSO to predict OS. The prognostic performance of the Rad-score was compared with a clinical model (demographics, disease stage, laboratory results) using Harrell’s concordance index (C-index) and bootstrapping. 140 patients were included, with a mortality rate was 72.9% during follow-up (total population, 19.5 ± 19.2 months; survivors, 34.4 ± 28.8 months). Eleven radiomics features were significant for survival prediction. The Rad-score predicted OS with a C-index of 0.681 [95% CI, 0.632–0.731]. A model integrating clinical parameters and Rad-score outperformed the clinical-only model in predicting OS (C-index 0.740 [0.715–0.816] vs. 0.673 [0.650–0.766]; C-index difference 0.067 [0.014–0.113]; P < 0.001). These findings suggest that incorporating FDG-PET/CT radiomics into preexisting prognotic stratification paradiagm may enhance survival prediction in PDAC, warranting large-scale studies to confirm its applicability in clinical practice.
format Article
id doaj-art-ea66fd4d4de840f299c32cc00e3b0023
institution OA Journals
issn 2045-2322
language English
publishDate 2024-11-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-ea66fd4d4de840f299c32cc00e3b00232025-08-20T02:22:26ZengNature PortfolioScientific Reports2045-23222024-11-011411910.1038/s41598-024-77022-4The value of PET/CT radiomics for predicting survival outcomes in patients with pancreatic ductal adenocarcinomaYeon-koo Kang0Seunggyun Ha1Ji Bong Jeong2So Won Oh3Department of Nuclear Medicine, Seoul National University Hospital, Seoul National University College of MedicineDivision of Nuclear Medicine, Department of Radiology, Seoul St. Mary’s Hospital, The Catholic University of Korea College of MedicineDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul Metropolitan Government - Seoul National University Boramae Medical Center, Seoul National University College of MedicineDepartment of Nuclear Medicine, Seoul Metropolitan Government - Seoul National University Boramae Medical Center, Seoul National University College of MedicineAbstract Pancreatic ductal adenocarcinoma (PDAC) is associated with poor prognosis even without distant metastases, necessitating in-depth characterization of primary tumors for survival prediction. We assessed the feasibility of using FDG-PET/CT radiomics to predict overall survival (OS) in PDAC. This retrospective study included PDAC patients without distant metastasis who underwent FDG-PET/CT for initial staging. Primary tumors were segmented from FDG-PET/CT images, extracting 222 radiomics features. A radiomics-based risk score (Rad-score) was developed using Cox proportional hazards regression with LASSO to predict OS. The prognostic performance of the Rad-score was compared with a clinical model (demographics, disease stage, laboratory results) using Harrell’s concordance index (C-index) and bootstrapping. 140 patients were included, with a mortality rate was 72.9% during follow-up (total population, 19.5 ± 19.2 months; survivors, 34.4 ± 28.8 months). Eleven radiomics features were significant for survival prediction. The Rad-score predicted OS with a C-index of 0.681 [95% CI, 0.632–0.731]. A model integrating clinical parameters and Rad-score outperformed the clinical-only model in predicting OS (C-index 0.740 [0.715–0.816] vs. 0.673 [0.650–0.766]; C-index difference 0.067 [0.014–0.113]; P < 0.001). These findings suggest that incorporating FDG-PET/CT radiomics into preexisting prognotic stratification paradiagm may enhance survival prediction in PDAC, warranting large-scale studies to confirm its applicability in clinical practice.https://doi.org/10.1038/s41598-024-77022-4FDG-PET/CTPancreas cancerRadiomicsSurvival
spellingShingle Yeon-koo Kang
Seunggyun Ha
Ji Bong Jeong
So Won Oh
The value of PET/CT radiomics for predicting survival outcomes in patients with pancreatic ductal adenocarcinoma
Scientific Reports
FDG-PET/CT
Pancreas cancer
Radiomics
Survival
title The value of PET/CT radiomics for predicting survival outcomes in patients with pancreatic ductal adenocarcinoma
title_full The value of PET/CT radiomics for predicting survival outcomes in patients with pancreatic ductal adenocarcinoma
title_fullStr The value of PET/CT radiomics for predicting survival outcomes in patients with pancreatic ductal adenocarcinoma
title_full_unstemmed The value of PET/CT radiomics for predicting survival outcomes in patients with pancreatic ductal adenocarcinoma
title_short The value of PET/CT radiomics for predicting survival outcomes in patients with pancreatic ductal adenocarcinoma
title_sort value of pet ct radiomics for predicting survival outcomes in patients with pancreatic ductal adenocarcinoma
topic FDG-PET/CT
Pancreas cancer
Radiomics
Survival
url https://doi.org/10.1038/s41598-024-77022-4
work_keys_str_mv AT yeonkookang thevalueofpetctradiomicsforpredictingsurvivaloutcomesinpatientswithpancreaticductaladenocarcinoma
AT seunggyunha thevalueofpetctradiomicsforpredictingsurvivaloutcomesinpatientswithpancreaticductaladenocarcinoma
AT jibongjeong thevalueofpetctradiomicsforpredictingsurvivaloutcomesinpatientswithpancreaticductaladenocarcinoma
AT sowonoh thevalueofpetctradiomicsforpredictingsurvivaloutcomesinpatientswithpancreaticductaladenocarcinoma
AT yeonkookang valueofpetctradiomicsforpredictingsurvivaloutcomesinpatientswithpancreaticductaladenocarcinoma
AT seunggyunha valueofpetctradiomicsforpredictingsurvivaloutcomesinpatientswithpancreaticductaladenocarcinoma
AT jibongjeong valueofpetctradiomicsforpredictingsurvivaloutcomesinpatientswithpancreaticductaladenocarcinoma
AT sowonoh valueofpetctradiomicsforpredictingsurvivaloutcomesinpatientswithpancreaticductaladenocarcinoma